室管膜瘤
医学
放射治疗
脊髓
磁共振成像
核医学
回顾性队列研究
外科
放射科
精神科
作者
Pranshu Mohindra,H. Ian Robins,Wolfgang A. Tomé,Lori L. Hayes,Steven Howard
出处
期刊:PubMed
[National Institutes of Health]
日期:2013-06-01
卷期号:33 (6): 2611-2618
被引量:20
摘要
AIM: This retrospective analysis evaluates feasibility of wide-field re-irradiation using pulsed reduced dose rate (PRDR) technique in patients with recurrent ependymoma. PRDR employs a dose rate of 6 cGy/min, as opposed to 400-600 cGy/min for conventional radiation, allowing for enhanced normal tissue repair. PATIENTS AND METHODS: Five patients with recurrent ependymoma having eight lesions (two brain, six spinal cord) were treated with PRDR. Progression-free survival (PFS) and overall survival (OS) were estimated by Kaplan Meier method. RESULTS: The median interval between two radiation courses was 58 months (range: 32-212 months). The median PRDR dose was 40 Gy (range: 30.6-54 Gy) with a median cumulative lifetime dose of 105.2 Gy (range: 90-162.4 Gy). At a median post-PRDR follow-up of 64 months, estimated 4-year OS and PFS from PRDR was 60% and 35.7%, respectively. None of the patients developed necrosis on serial magnetic resonance imaging scans, and only one patient had progressive mild radiculopathy. CONCLUSION: In patients with large-volume recurrent ependymoma, re-irradiation with wide-field PRDR is a feasible option.
科研通智能强力驱动
Strongly Powered by AbleSci AI